Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14883391 | 1.00 | ALDH1A1 (0.32) | ALDH1A1LMNAHSD17B10KDM4ECYP2C19 | |
| SCHEMBL13649534 | 1.00 | ALDH1A1 (0.32) | ALDH1A1LMNAHSD17B10KDM4ECYP2C19 | |
| SCHEMBL143845 | 0.98 | ALDH1A1 (0.33) | ALDH1A1LMNAHSD17B10MEN1KMT2A | |
| SCHEMBL13104282 | 0.93 | ALDH1A1 (0.33) | ALDH1A1LMNAHSD17B10 | |
| SCHEMBL15492447 | 0.89 | — | — | |
| SCHEMBL14990797 | 0.84 | CYP2C19 (0.31) | ALDH1A1LMNAKDM4ECYP2C19MEN1 | |
| SCHEMBL20484018 | 0.84 | CYP2C19 (0.31) | ALDH1A1LMNAKDM4ECYP2C19MEN1 | |
| SCHEMBL8978123 | 0.83 | CETP (0.32) | ALDH1A1LMNAHSD17B10MEN1KMT2A | |
| SCHEMBL20484020 | 0.83 | CYP2C19 (0.34) | ALDH1A1LMNAKDM4ECYP2C19MEN1 | |
| SCHEMBL14655770 | 0.83 | KDM4E (0.30) | KDM4ECYP2C19MEN1KMT2ACYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1170343-B1 | INFRARED SENSITIVE COATING LIQUID | ASAHI KASEI CHEMICALS CORP (JP) | 2005-11-02 | — | — | EP | claimed |
| US-6653046-B2 | Flexography printing plates; drawing images; using ester solvents | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2003-11-25 | — | — | US | claimed |
| US-20020187429-A1 | Infrared sensitive coating liquid | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2002-12-12 | — | — | US | claimed |
| US-6369279-B1 | STYRENE WITH ETHER OR FLUORINE GROUPS FOR POLYMERS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-04-09 | — | — | US | claimed |
| EP-1170343-A1 | INFRARED SENSITIVE COATING LIQUID | Asahi Kasei Kabushiki Kaisha (JP) | 2002-01-09 | — | — | EP | claimed |
| EP-3902878-B1 | PHOTOINITIATORS | IGM RESINS ITALIA SRL (IT) | 2026-05-06 | — | — | EP | disclosed |
| WO-2024149992-A1 | IMAGING COMPOUNDS FOR DETECTING OR IMAGING SENESCENT CELLS | UNIVERSITY OF DUNDEE (GB) | 2024-07-18 | — | — | WO | disclosed |
| US-20240210824-A1 | CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-06-27 | — | — | US | disclosed |
| WO-2024115760-A1 | ESTERS AND ETHERS OF 5-ISOPROPYL-2-METHYLCYCLOHEXAN-1-OL AS FRAGRANCE INGREDIENTS | BASF SE (DE) | 2024-06-06 | — | — | WO | disclosed |
| WO-2024100276-A2 | SUBSTITUTED 1,3-DIOXOLAN-4-ONES AND 1,3-DIOXAN-4-ONES AS FRAGRANCE INGREDIENTS | BASF SE (DE) | 2024-05-16 | — | — | WO | disclosed |
| WO-2024100254-A1 | DIMETHYL ACRYLIC ACID-BASED COMPOUNDS AS AROMA INGREDIENTS | BASF SE (DE) | 2024-05-16 | — | — | WO | disclosed |
| WO-2024068860-A1 | OLIGOMERIC BINAPHTYL COMPOUNDS AND THERMOPLASTIC RESINS | REUTER CHEMISCHE APPARATEBAU E.K. (DE) | 2024-04-04 | — | — | WO | disclosed |
| EP-1170343-A1 | INFRARED SENSITIVE COATING LIQUID | Asahi Kasei Kabushiki Kaisha (JP) | 2002-01-09 | — | — | EP | disclosed |
| US-6333436-B1 | Styrene derivatives | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-12-25 | — | — | US | disclosed |
| US-20010051741-A1 | Novel ester compounds having alicyclic structure and method for preparing same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-12-13 | — | — | US | disclosed |
| US-20010051742-A1 | Novel ester compounds having alicyclic structure and method for preparing same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-12-13 | — | — | US | disclosed |
| US-20010038971-A1 | Chemical amplification, positive resist compositions | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-11-08 | — | — | US | disclosed |
| EP-1149826-A2 | Ester compounds having alicyclic structure, and methods for preparing the same | Shin-Etsu Chemical Co., Ltd. (JP) | 2001-10-31 | — | — | EP | disclosed |
| US-20010033994-A1 | Chemical amplification, positive resist compositions | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-10-25 | — | — | US | disclosed |
| EP-1077391-A1 | Onium salts, photoacid generators for resist compositions, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-02-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240210824-A1 | CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SCO2, CBR1, OXGR1 | ALDH1A1 492/4885LMNA 4690/4885HSD17B10 729/4885 |
| US-20010051742-A1 | Novel ester compounds having alicyclic structure and method for preparing same | ARCN1, ECH1, GAR1 | ALDH1A1 460/4885LMNA 218/4885HSD17B10 960/4885 |
| US-20010051741-A1 | Novel ester compounds having alicyclic structure and method for preparing same | ARCN1, ECH1, ASIC1 | ALDH1A1 421/4885LMNA 228/4885HSD17B10 1786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.